Significance of a solitary perivascular mononuclear infiltrate in lung allograft recipients with mild acute cellular rejection

Journal of Heart and Lung Transplantation

Volumn 24, Issue 2, 2005, Pages 152-155

  Kim, Dong Won ^a   Dacic, Sanja ^a   Iacono, Aldo ^a   Grgurich, Wayne ^a   Yousem, Samuel A ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; AGED; ANAMNESIS; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EMPHYSEMA; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG BIOPSY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; OUTCOMES RESEARCH; PARAMETER; PRIORITY JOURNAL; RECIPIENT; SOLITARY PERIVASCULAR MONONUCLEAR INFILTRATE; SURGICAL PATIENT;

EID: 13444251373     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.10.024     Document Type: Article

References (15)

1. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection Lung Rejection Study Group. J Heart Lung Transplant. 15:1996;1-15
2. Bando K., Paradis I.L., Komatsu K., et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg. 109:1995;49-57
3. Bando K., Paradis I.L., Similo S., et al. Obliterative bronchiolitis after lung and heart-lung transplantation an analysis of risk factors and management. J Thorac Cardiovasc Surg. 110:1995;4-13
4. Reinsmoen N.L., Bolman R.M., Savik K., Butters K., Hertz M.I. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection? Transplantation. 55:1993;1040-1044
5. Hasegawa S., Ockner D.M., Ritter J.H., et al. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocytes subset immunotyping in chronic pulmonary transplant rejection. Arch Pathol Lab Med. 119:1995;432-439
6. Whitehead B., Rees P., Sorensen K., et al. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. J Heart Lung Transplant. 12:1993;903-908
7. Girgis R.E., Tu I., Berry G.J., et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 15:1996;1200-1208
8. Scott J.P., Higenbottam T.W., Sharples L., et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation. 51:1991;813-817
9. Sharples L., Tamm M., McNeil K., Higenbottam T.W., Stewart S., Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation early risk factors. Transplantation. 61:1996;560-566
10. Yousem S.A. Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients. Hum Pathol. 27:1996;269-273
11. Vitulo P., Cremaschi P., Arbustini E., et al. Surveillance transbronchial biopsy in the diagnosis of acute lung rejection in heart and lung and lung transplant recipients. Monaldi Arch Chest Dis. 51:1996;12-15
12. Clelland C.A., Higenbottam T.W., Stewart S., Scott J.P., Wallwork J. The histological changes in transbronchial biopsy after treatment of acute lung rejection in heart-lung transplants. J Pathol. 161:1990;105-112
13. Clelland C., Higenbottam T., Otulana B., et al. Histologic prognostic indicators for the lung allografts of heart-lung transplants. J Heart Lung Transplant. 9:1990;177-185
14. Yousem S.A., Dauber J.A., Keenan R., Paradis I.L., Zeevi A., Griffith B.P. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation. 52:1991;306-309
15. Husain A.N., Siddiqui M.T., Holmes E.W., et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 159:1999;829-833